| Item Type | Name |
|
Concept
|
Bone Marrow Cells
|
|
Concept
|
Bone Marrow Diseases
|
|
Concept
|
Bone Marrow
|
|
Concept
|
Myelodysplastic Syndromes
|
|
Concept
|
Neoplastic Syndromes, Hereditary
|
|
Concept
|
Bone Marrow Transplantation
|
|
Concept
|
Syndrome
|
|
Concept
|
Kidney Failure, Chronic
|
|
Concept
|
Rett Syndrome
|
|
Concept
|
Li-Fraumeni Syndrome
|
|
Academic Article
|
TTID: A novel gene at 5q31 encoding a protein with titin-like features.
|
|
Academic Article
|
Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene.
|
|
Academic Article
|
cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
|
|
Academic Article
|
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
|
|
Academic Article
|
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.
|
|
Academic Article
|
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
|
|
Academic Article
|
5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.
|
|
Academic Article
|
Profiles in leukemia.
|
|
Academic Article
|
Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.
|
|
Academic Article
|
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
|
|
Academic Article
|
Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes.
|
|
Academic Article
|
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Node-pore sensing enables label-free surface-marker profiling of single cells.
|
|
Academic Article
|
Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
|
|
Academic Article
|
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
|
|
Academic Article
|
Correspondence Regarding the Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
|
|
Academic Article
|
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.
|
|
Academic Article
|
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
|
|
Academic Article
|
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
|
|
Academic Article
|
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.
|
|
Academic Article
|
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
|
|
Academic Article
|
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.
|
|
Academic Article
|
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.
|
|
Academic Article
|
Genetic predisposition to leukemia and other hematologic malignancies.
|
|
Academic Article
|
Cytogenetic responses to a 5-day dosing schedule of decitabine in patients (Pts) with myelodysplastic syndromes (MDS).
|
|
Academic Article
|
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS).
|
|
Academic Article
|
Germline ETV6 mutations and predisposition to hematological malignancies.
|
|
Academic Article
|
Therapy-related myeloid neoplasms: when genetics and environment collide.
|
|
Academic Article
|
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
|
|
Academic Article
|
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis.
|
|
Academic Article
|
Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome.
|
|
Academic Article
|
Inherited Thrombocytopenia Caused by Germline ANKRD26 Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome.
|
|
Academic Article
|
Germline mutations in MDS/AML predisposition disorders.
|
|
Academic Article
|
Germline variants drive myelodysplastic syndrome in young adults.
|
|
Academic Article
|
Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes.
|
|
Academic Article
|
Genetics of Myelodysplastic Syndromes.
|
|
Academic Article
|
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias.
|
|
Academic Article
|
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
|
|
Academic Article
|
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.
|
|
Academic Article
|
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
|
|
Academic Article
|
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia.
|
|
Academic Article
|
Classification of rare pediatric myeloid neoplasia-Quo vadis?
|
|
Grant
|
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
|
|
Academic Article
|
Germ line risk variants: beyond cancer.
|
|
Academic Article
|
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.
|
|
Academic Article
|
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
|
|
Academic Article
|
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
|